Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maribel Díaz-Ricart

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Cellular and Molecular Medicine|November 30, 2019
Up-regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotideMarta Palomo, Manel Vera, Susana Martin, et al.
Psychoneuroendocrinology|September 19, 2009
Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatmentEsther Gómez-Gil, Ricard Navinés, M Jesús Martínez De Osaba, et al.
Journal of Biomedical Materials Research. Part A|December 22, 2016
Cell adhesive peptides functionalized on CoCr alloy stimulate endothelialization and prevent thrombogenesis and restenosisMaria Isabel Castellanos, Jordi Guillem-Marti, Carlos Mas-Moruno, et al.
Transfusion|April 5, 2019
Idarucizumab, but not procoagulant concentrates, fully restores dabigatran-altered platelet and fibrin components of hemostasisEduardo Arellano-Rodrigo, Victor Fernandez-Gallego, Irene López-Vilchez, et al.
Transfusion Medicine Reviews|September 14, 2015
Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy VolunteersEduardo Arellano-Rodrigo, Irene Lopez-Vilchez, Ana M Galan, et al.
Journal of Cellular and Molecular Medicine|June 11, 2020
Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host diseaseDavid García-Bernal, Marta Palomo, Carlos M Martínez, et al.
Journal of Thrombosis and Haemostasis : JTH|April 19, 2021
Progressive endothelial cell damage in correlation with sepsis severity. Defibrotide as a contenderSara Fernández, Marta Palomo, Patricia Molina, et al.
Cytometry. Part B, Clinical Cytometry|May 13, 2026
Diagnostic performance of flow cytometric osmotic fragility testing in hereditary spherocytosisSilvia Escribano Serrat, Patricia Molina, Pilar Gómez, et al.
Expert Opinion on Therapeutic Targets|June 25, 2021
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromesEdward Richardson, David García-Bernal, Eleonora Calabretta, et al.
Bone Marrow Transplantation|March 24, 2024
Improving the EASIX' predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantationSilvia Escribano-Serrat, Luis Gerardo Rodríguez-Lobato, María Suárez-Lledó, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Cellular and Molecular Medicine|November 30, 2019
Up-regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotideMarta Palomo, Manel Vera, Susana Martin, et al.
Psychoneuroendocrinology|September 19, 2009
Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatmentEsther Gómez-Gil, Ricard Navinés, M Jesús Martínez De Osaba, et al.
Journal of Biomedical Materials Research. Part A|December 22, 2016
Cell adhesive peptides functionalized on CoCr alloy stimulate endothelialization and prevent thrombogenesis and restenosisMaria Isabel Castellanos, Jordi Guillem-Marti, Carlos Mas-Moruno, et al.
Transfusion|April 5, 2019
Idarucizumab, but not procoagulant concentrates, fully restores dabigatran-altered platelet and fibrin components of hemostasisEduardo Arellano-Rodrigo, Victor Fernandez-Gallego, Irene López-Vilchez, et al.
Transfusion Medicine Reviews|September 14, 2015
Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy VolunteersEduardo Arellano-Rodrigo, Irene Lopez-Vilchez, Ana M Galan, et al.
Journal of Cellular and Molecular Medicine|June 11, 2020
Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host diseaseDavid García-Bernal, Marta Palomo, Carlos M Martínez, et al.
Journal of Thrombosis and Haemostasis : JTH|April 19, 2021
Progressive endothelial cell damage in correlation with sepsis severity. Defibrotide as a contenderSara Fernández, Marta Palomo, Patricia Molina, et al.
Cytometry. Part B, Clinical Cytometry|May 13, 2026
Diagnostic performance of flow cytometric osmotic fragility testing in hereditary spherocytosisSilvia Escribano Serrat, Patricia Molina, Pilar Gómez, et al.
Expert Opinion on Therapeutic Targets|June 25, 2021
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromesEdward Richardson, David García-Bernal, Eleonora Calabretta, et al.
Bone Marrow Transplantation|March 24, 2024
Improving the EASIX' predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantationSilvia Escribano-Serrat, Luis Gerardo Rodríguez-Lobato, María Suárez-Lledó, et al.
Pageof 6